WeTrials
Recruiting

An Open-Label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

What is this study?

This study is testing a medication called inebilizumab in children and teenagers with neuromyelitis optica spectrum disorder, a rare condition affecting the central nervous system. Researchers want to see how the medication behaves in younger bodies, how safe it is, and how well it helps control the disease.

Who can participate?

Children and teenagers aged 2 to under 18 who weigh at least 33 pounds and have a confirmed diagnosis of the condition with specific antibodies in their blood may join. Participants must also have a history of recent flare-ups and meet overall health requirements set by the study doctors.

What will happen?

Participants will receive the study medication, inebilizumab, which targets specific immune cells involved in the condition. The medical team will closely monitor their health, safety, and how the drug affects their body through regular check-ups and lab tests.

Where and when?

This study is currently recruiting participants at locations in California and Massachusetts within the United States. You can talk to your doctor or the study team to find the most convenient location and learn more about getting involved.

Key Points
  • 1Testing the safety and effects of inebilizumab in pediatric patients
  • 2Open to children and teens aged 2 to 17 with specific antibodies
  • 3Currently recruiting patients at select medical centers in the US

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Neuromyelitis Optica Spectrum Disorder

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.

An Open-Label Multicenter Study to Evaluate the… | WeTrials Trial Guide